experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism

June 2012

You'll hear experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism.

There are good points on both sides.

Subclinical HYPOthyroidism is associated with an increased risk of ischemic heart disease, cardiovascular events, and mortality.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote